^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    D2C7

    i
    Other names: D2C7, D2C7 Immunotoxin, D2C7 IT, D2C7-IT
    Associations
    News
    Trials
    Company:
    Duke University, Istari Oncology
    Drug class:
    Elongation factor 2 inhibitor, EGFRvIII-targeted antibody-immunotoxin conjugate, EGFRwt-targeted antibody-immunotoxin conjugate
    Related drugs:
    Associations
    News
    Trials